The long-lived and highly proliferating lymphoma B-cells are favored by excessive mTOR pathway activation, which is correlated to poor prognosis in NHL and B-cell acute lymphoblastic leukemia (LAL-B) patients [58]. This evidence concerns the gene MTOR and non-Hodgkin lymphoma.